Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIVHEART Transcatheter Aortic Valve Replacement (TAVR) Self-centering Catheter First-in-human Feasibility Trial (VIV-FIH)

NCT06412354 is registered in ClinicalTrials.gov with Vivheart s.r.l. as lead sponsor.

NCT NCT06412354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06412354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIVHEART Transcatheter Aortic Valve Replacement (TAVR) Self-centering Catheter First-in-human Feasibility Trial (VIV-FIH)
Lead sponsor
Vivheart s.r.l.
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2024
Completion date
July 15, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve replacement (tavr)